Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 1631 entries
View as:

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00961038 Org: User:
Start: 08/31/09 End: 03/31/10 Due: 03/31/11

Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00928967 Org: User:
Start: 05/31/07 End: 11/30/10 Due: 11/30/11

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

Phase: N/A Priority: Normal
NCT ID: NCT01465009 Org: User:
Start: 11/30/03 End: 03/31/05 Due: 03/31/06

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

Phase: N/A Priority: Normal
NCT ID: NCT05030584 Org: User:
Start: 08/27/21 End: 02/12/24 Due: 02/12/25

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

Phase: N/A Priority: Normal
NCT ID: NCT04249401 Org: User:
Start: 03/01/20 End: 09/30/23 Due: 09/30/24

Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

Phase: N/A Priority: Normal
NCT ID: NCT01468545 Org: User:
Start: 10/31/11 End: 06/30/14 Due: 06/30/15

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Phase: N/A Priority: Normal
NCT ID: NCT01890421 Org: User:
Start: 07/19/13 End: 08/31/17 Due: 08/31/18

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Phase: N/A Priority: Normal
NCT ID: NCT04722991 Org: User:
Start: 03/17/21 End: 04/22/24 Due: 04/22/25

Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily

Phase: N/A Priority: Normal
NCT ID: NCT02549469 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01172756 Org: User:
Start: 07/31/10 End: 10/31/12 Due: 10/31/13

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01771081 Org: User:
Start: 04/30/13 End: 04/30/15 Due: 04/30/16

Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes

Phase: N/A Priority: Normal
NCT ID: NCT01928888 Org: User:
Start: 05/31/03 End: 02/29/04 Due: 02/28/05

Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)

Phase: N/A Priority: Normal
NCT ID: NCT00915915 Org: User:
Start: 06/30/09 End: 04/30/10 Due: 04/30/11

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD

Phase: N/A Priority: Normal
NCT ID: NCT02279537 Org: User:
Start: 01/02/14 End: 04/17/19 Due: 04/17/20

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT02234843 Org: User:
Start: 11/13/14 End: 01/30/19 Due: 01/30/20

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01412398 Org: User:
Start: 04/07/09 End: 09/01/16 Due: 09/01/17

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

Phase: N/A Priority: Normal
NCT ID: NCT01253187 Org: User:
Start: 10/31/06 End: 09/30/07 Due: 09/30/08

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00313248 Org: User:
Start: 04/30/06 End: 11/30/08 Due: 11/30/09

REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00874679 Org: User:
Start: 03/31/07 End: 04/30/10 Due: 04/30/11

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Phase: N/A Priority: Normal
NCT ID: NCT06204302 Org: User:
Start: 01/05/24 End: 04/04/24 Due: 04/04/25

Study to Learn More About the Effect of Itraconazole (ITZ) Given Repeatedly by Mouth on the Way How the Study Drug BAY1902607 Given One Time by Mouth Acts in the Human Body of Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03789890 Org: User:
Start: 01/08/19 End: 05/23/19 Due: 05/23/20

A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Phase: N/A Priority: Normal
NCT ID: NCT02034552 Org: User:
Start: 03/07/14 End: 06/26/18 Due: 06/26/19

SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study

Phase: N/A Priority: Normal
NCT ID: NCT00511797 Org: User:
Start: 07/31/07 End: 01/31/09 Due: 01/31/10

Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00682019 Org: User:
Start: 12/31/03 End: 08/31/04 Due: 08/31/05

A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT07023341 Org: User:
Start: 06/20/25 End: 04/28/28 Due: 04/28/29